Cutting Edge: ATP13A2 Is an Endolysosomal Regulator of TLR9/7 Activation in Human Plasmacytoid Dendritic Cells.
Journal
Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R
Informations de publication
Date de publication:
15 Jul 2024
15 Jul 2024
Historique:
received:
03
11
2023
accepted:
05
05
2024
medline:
1
7
2024
pubmed:
1
7
2024
entrez:
1
7
2024
Statut:
ppublish
Résumé
ATPase cation transporting 13A2 (ATP13A2) is an endolysosomal P-type ATPase known to be a polyamine transporter, explored mostly in neurons. As endolysosomal functions are also crucial in innate immune cells, we aimed to explore the potential role of ATP13A2 in the human immunocellular compartment. We found that human plasmacytoid dendritic cells (pDCs), the professional type I IFN-producing immune cells, especially have a prominent enrichment of ATP13A2 expression in endolysosomal compartments. ATP13A2 knockdown in human pDCs interferes with cytokine induction in response to TLR9/7 activation in response to bona fide ligands. ATP13A2 plays this crucial role in TLR9/7 activation in human pDCs by regulating endolysosomal pH and mitochondrial reactive oxygen generation. This (to our knowledge) hitherto unknown regulatory mechanism in pDCs involving ATP13A2 opens up a new avenue of research, given the crucial role of pDC-derived type I IFNs in protective immunity against infections as well as in the immunopathogenesis of myriad contexts of autoreactive inflammation.
Identifiants
pubmed: 38950331
pii: 266927
doi: 10.4049/jimmunol.2300733
doi:
Substances chimiques
Toll-Like Receptor 9
0
TLR9 protein, human
0
ATP13A2 protein, human
0
Proton-Translocating ATPases
EC 3.6.3.14
TLR7 protein, human
0
Reactive Oxygen Species
0
Interferon Type I
0
Toll-Like Receptor 7
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109-114Subventions
Organisme : Department of Science and Technology, Government of Rajasthan (DST)
ID : DST/SJF/LSA-3/2-16-17
Informations de copyright
Copyright © 2024 by The American Association of Immunologists, Inc.